|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Vivos Therapeutics, Inc. (VVOS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
0 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vivos Therapeutics is a medical technology company focused on the development and commercialization of a suite of diagnostic and treatment modalities for patients with dentofacial abnormalities and/or patients with mild to moderate obstructive sleep apnea (OSA) and snoring in adults. Co. calls its OSA treatment protocol The Vivos Method. The Vivos Method is a therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical protocols developed by Co. and prescribed by trained dentists in cooperation with their medical colleagues.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
10,000 |
42,000 |
| Total Buy Value |
$0 |
$0 |
$4,900 |
$38,460 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Huntsman Ronald Kirk |
Chief Executive Officer |
• • – |
2023-06-14 |
4 |
B |
$0.49 |
$4,900 |
D/D |
10,000 |
57,500 |
2.73 |
- |
|
| Huntsman Ronald Kirk |
Chief Executive Officer |
• • • |
2022-12-23 |
4 |
B |
$0.50 |
$10,000 |
D/D |
20,000 |
47,500 |
3.15 |
- |
|
| Huntsman Ronald Kirk |
Chief Executive Officer |
• • • |
2022-06-01 |
4 |
B |
$1.83 |
$7,320 |
D/D |
4,000 |
27,500 |
3.15 |
- |
|
| Huntsman Ronald Kirk |
Chief Executive Officer |
• • • |
2022-05-31 |
4 |
B |
$2.03 |
$16,240 |
D/D |
8,000 |
23,500 |
3.15 |
- |
|
| Huntsman Ronald Kirk |
Chief Executive Officer |
• • – |
2021-09-21 |
4 |
B |
$4.31 |
$21,550 |
D/D |
5,000 |
15,500 |
2.81 |
- |
|
| Huntsman Ronald Kirk |
Chief Executive Officer |
• • – |
2021-08-17 |
4 |
B |
$3.00 |
$15,000 |
D/D |
5,000 |
10,500 |
2.81 |
- |
|
| Amman Bradford K. |
Chief Financial Officer |
• – – |
2021-05-25 |
4 |
B |
$5.29 |
$5,290 |
D/D |
1,000 |
2,000 |
2.74 |
- |
|
| Huntsman Ronald Kirk |
Chief Executive Officer |
• • – |
2021-05-25 |
4 |
B |
$5.38 |
$21,520 |
D/D |
4,000 |
5,500 |
2.81 |
- |
|
| Amman Bradford K. |
Chief Financial Officer |
• – – |
2020-12-24 |
4 |
B |
$7.38 |
$7,380 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| Huntsman Ronald Kirk |
Chief Executive Officer |
• • • |
2020-12-23 |
4 |
B |
$7.27 |
$7,267 |
D/D |
1,000 |
1,500 |
3.15 |
- |
|
| Huntsman Ronald Kirk |
Chief Executive Officer |
• • • |
2020-12-11 |
4 |
B |
$8.50 |
$4,250 |
D/D |
500 |
500 |
3.15 |
- |
|
| Singh Gurdev Dave |
Chief Medical OfficerOfficer |
• • • |
2020-12-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
700,000 |
|
- |
|
| Singh Gurdev Dave |
Chief Medical OfficerOfficer |
• • • |
2020-12-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,219,705 |
|
- |
|
| Huntsman Ronald Kirk |
Chairman & CEOOfficer |
• • • |
2020-12-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,749,000 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
